🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

First communication from the European GI network #Engic . Collaboration between Fédération Francophone de Cancérologie Digestive and #Gono on Engic02-PRODIGE 86 : LA or M+ small Bowel carcinoma. Design paper. Chiara Cremolini

🚨 New #LowerGI cancer data from #ESMO24 🚨 Profs. Chiara Cremolini & Hans Prenen joined us at the congress to each share their insights on new rectal & colorectal cancer data from NICHE-2, NICHE-3 & IMHOTEP trials. 📺Watch their video update Supported by Bayer #Meded #CRC

#LowerGI oncology highlights from #ESMO24 📣 Profs. Chiara Cremolini & Hans Prenen give an overview of the new data from a range of trials presented at the congress, and how this data will impact the clinic ow.ly/V8qp50Tv5om Supported by an independent #MedEd grant from Bayer

Had the chance to present the phase 1 TriComB study results at AIOM24 - Paolo Ciracì AIOM oncodaily.com/url/183348 #AIOM24 #Cancer #ClinicalTrials #CRCsm #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Catch the #LowerGI oncology highlights from #ESMO24 📣 👉 ow.ly/3eYn50U563K Profs. Chiara Cremolini & Hans Prenen explore how new data from a range of trials could impact clinical practice. Don't miss out! Supported by an independent #MedEd grant from Bayer

Check out this clinically meaningful analysis by Lisa Salvatore & coworkers The Lancet Oncology

TricomB by GONO Foundation … phase II data coming soon!

Describing a molecular subgroup with clinical implications, hopefully! Paolo Ciracì Vittorio Studiale Daniele Rossini

This study reveals malignant ascites as a key marker of poor survival in advanced gastrointestinal cancers with peritoneal metastases. Learn how these findings inform #GastroesophagealCancer care and research: journals.sagepub.com/doi/epdf/10.11…

PD-L1 thresholds predict efficacy of immune checkpoint inhibition in 1st line GC/GEJ cancer ESMO Open doi.org/10.1016/j.esmo… 🔎systematic review & meta-analysis, 11 phs 3 trials 👉PD-L1 CPS 5 acceptable cut-off to optimize risk/benefit 👉we need additional biomarkers for CPS

💡Late-line #mCRC : an evidence-based algorithm for the clinical practice in 2024 Proud and thrilled to share our review on the topic now online in NatureRevClinOncol ! Read the full article at rdcu.be/d0AHE Paolo Ciracì carlottanto Chiara Cremolini #Oncology #cancer

Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm An excellent review👇 nature.com/articles/s4157…

In this new article now live online, Paolo Ciracì, Vittorio Studiale, Ada Taravella, carlottanto & Chiara Cremolini Review the late-line therapeutic options for patients with metastatic colorectal cancer and provide an evidence-based treatment algorithm: nature.com/articles/s4157…

Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm Out on Nature Reviews Clinical Oncology In recent years, several novel systemic treatments have become available for patients with treatment-refractory metastatic colorectal

Tremelimumab and durvalumab as neoadjuvant or non-operative management of pts with MSI gastric cancer. First trial to show that these patients can live with their stomach after this diagnosis! sciencedirect.com/science/articl…

An excellent #crcsm review in nature by Chiara Cremolini and colleagues More 🎯tx inc: #Lonsurf 💊+ bevacizumab 💊fruquintinib #HER2 therapies💉 #KRAS G12C #ctDNA may identify target or resistance mutations. 🔗: nature.com/articles/s4157… #GIonc OncoAlert🚨 #OncoAlertAF

A successful trial by GONO Foundation , a brilliant effort of academic research. Congrats Filippo Pietrantonio and team!!!

The OncoAlert 🚨Newsletter NOW OUT Covering September November 28-Dec 5, 2024 REGISTER AT OncoAlert360.com OR buff.ly/48Xpgz0 Discussing ✅FDA Approves Duvalumab in #SCLC 🫁🇺🇸 ✅FDA ACCELERATED APPROVAL TO ZENOCUTUZUMAB-ZBCO IN #NSCLC 🫁 ✅Lung

Wanted to share this masterpiece review article - A delightful must-read for people interested in late-line colorectal cancer treatments! Very comprehensive and updated. Chiara Cremolini #colorectalcancer Colorectal Cancer Alliance COLONTOWN nature.com/articles/s4157…

#tumoredelcolon e dell'upper GI: guarda l'intervista su #AIOMTv. youtube.com/live/wVvm7aSCe… Chiara Cremolini Filippo Pietrantonio #oncologia #cancro